Lanean...
Antidepressant-like properties of sarizotan in experimental Parkinsonism
RATIONALE: Depression and anxiety are common symptoms in Parkinson's disease for which there are no optimal treatments. Sarizotan, an agonist at serotonin receptors and partial agonist at dopamine D(2)-like receptors, has shown antidyskinetic effects in Parkinson's disease. Based on its ph...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer-Verlag
2011
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3222806/ https://ncbi.nlm.nih.gov/pubmed/21647579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00213-011-2356-7 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|